Nasal Nitric Oxide Is Correlated With Nasal Patency and Nasal Symptoms
10.4168/aair.2019.11.3.367
- Author:
Lei REN
1
;
Wei ZHANG
;
Yuan ZHANG
;
Luo ZHANG
Author Information
1. Department of Allergy, Beijing Tongren Hospital, Capital Medical University, Beijing, China. dr.luozhang@139.com, ummer_zhang1211@126.com
- Publication Type:Original Article
- Keywords:
Nitric oxide;
allergic rhinitis;
rhinitis;
Chinese;
nasal obstruction;
atopic
- MeSH:
Adult;
Asian Continental Ancestry Group;
Body Weight;
Diagnosis;
Humans;
Nasal Obstruction;
Nitric Oxide;
Reference Values;
Respiratory System;
Rhinitis;
Rhinitis, Allergic;
Sensitivity and Specificity;
Skin
- From:Allergy, Asthma & Immunology Research
2019;11(3):367-380
- CountryRepublic of Korea
- Language:English
-
Abstract:
PURPOSE: Nitric oxide (NO) is an important endogenous mediator in both upper and lower respiratory systems. The purpose of the present study was to extract nasal NO (nNO) normal range of Chinese adults and the internal influencing factors. The differences in nNO levels between rhinitis and asymptomatic atopic subjects, and the diagnostic value of nNO in allergic rhinitis (AR) were further investigated. METHODS: One thousand adults were recruited from the general public. Participants were divided into different subgroups according to the questionnaires and skin prick tests. In all of these subjects, nNO, fractional exhaled NO (FeNO) and nasal airflow resistance were measured. The normal ranges of nNO and FeNO, the differences between subgroups, and the correlations between NO (nNO and FeNO) and other internal factors were analyzed. RESULTS: Both nNO and FeNO levels were significantly higher in AR patients than in healthy and asymptomatic atopic subjects. The nNO levels were significantly lower in asymptomatic atopic subjects than in normal adults. FeNO levels were significantly higher in non-AR patients than in the healthy and asymptomatic atopic adults. The cutoff value of nNO for the diagnosis of AR was 117.5 ppb (sensitivity, 50.9%; specificity, 63.9%). The nNO levels were correlated with FeNO levels, total nasal resistance measured at 75Pa, nasal volume within 0–7 cm from the anterior nares (V0–7cm) and nasal symptom visual analogue scale (VAS) scores, while the FeNO levels were correlated with age, height, weight, body surface area, nasal volume of V0–7cm and the nasal symptom VAS score. CONCLUSIONS: The nNO level can be significantly different between healthy and AR patients and may be significantly correlated with nasal symptoms and nasal patency of rhinitis patients. However, the clinical value of nNO is still in the exploration stage.
